Due to paucity of time during the COVID-19 crisis, we limited the number of collected variables and we were unable to report important data such as the use of angiotensin-converting enzyme inhibitors, focal or non-focal lung morphology, or inflammatory markers. This evidence concerns the gene ACE and COVID-19.